0001193125-21-326190 Sample Contracts

CIDARA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20 Debt Securities

Indenture • November 10th, 2021 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Indenture
• Filed
  November 10th, 2021
• Company
  Cidara Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

INDENTURE, dated as of [●], 20 , among CIDARA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

CIDARA THERAPEUTICS, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20

Common Stock Warrant Agreement • November 10th, 2021 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  November 10th, 2021
• Company
  Cidara Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CIDARA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

CIDARA THERAPEUTICS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20

Warrant Agreement • November 10th, 2021 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Warrant Agreement
• Filed
  November 10th, 2021
• Company
  Cidara Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between CIDARA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

CIDARA THERAPEUTICS, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20

Preferred Stock Warrant Agreement • November 10th, 2021 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  November 10th, 2021
• Company
  Cidara Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CIDARA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).